ACE/CD143 Antibody (JM59-32)

ACE converts angiotensin I to angiotensin II by release of the terminal His-Leu, this results in an increase of the vasoconstrictor activity of angiotensin. Also able to inactivate bradykinin, a potent vasodilatator. ACE exists in two forms, a 170KD somatic form and a 90KD germinal form. The somatic form is expressed by endothelial cells (especially those of lung capillaries and arterioles), epithelial cells (especially in proximal renal tubules and small intestine), by some neuronal cells and variably by some macrophages and T lymphocytes. The germinal form is expressed by spermatozoa.

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

We have publications tested in 1 confirmed species: Mouse.

We have publications tested in 1 application: IHC-P.

Showing Publication 1 - 1 of 1.

Publication using NBP2-67111	Applications	Species
Yin Y, Cao S, Fu H et al. A noncanonical role of NOD-like receptor NLRP14 in PGCLC differentiation and spermatogenesis Proc Natl Acad Sci U S A 2020-09-08 [PMID: 32839316] (IHC-P, Mouse)	IHC-P	Mouse

Array NBP2-67111

• ACE/CD143 Antibodies
• ACE/CD143 ELISA Kits
• ACE/CD143 Kit
• ACE/CD143 Proteins
• ACE/CD143 Proteins and Enzymes
• ACE/CD143 ELISAs